Patent: 9,458,172
✉ Email this page to a colleague
Summary for Patent: 9,458,172
Title: | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
Abstract: | Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds. |
Inventor(s): | Bair; Kenneth W (Watertown, MA), Baumeister; Timm R (Watertown, MA), Dragovich; Peter (South San Francisco, CA), Gosselin; Francis (South San Francisco, CA), Yuen; Po-Wai (Beijing BDA, CN), Zak; Mark (South San Francisco, CA), Zheng; Xiaozhang (Watertown, MA) |
Assignee: | |
Application Number: | 14/382,123 |
Patent Claims: | see list of patent claims |
Details for Patent 9,458,172
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2032-03-02 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2032-03-02 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2032-03-02 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2032-03-02 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |